Monitor for appointment of a permanent CFO and any updates on Vir Bio's pipeline or financial strategy. The interim CFO is an internal appointee with deep accounting experience, so near-term disruption is minimal.
Price Chart
Executive Summary
Vir Biotechnology disclosed that CFO Jason O'Byrne will step down on August 3, 2026 to pursue another opportunity, with no disagreement cited. The company appointed Brent Sabatini, SVP and CAO, as interim principal financial officer effective the same date, and has initiated a search for a permanent successor. This is a routine executive transition with no financial impact disclosed.
Key Facts
- CFO Jason O'Byrne resigning effective August 3, 2026 to pursue another opportunity
- No disagreement with Vir Bio's operations, policies, or practices
- Brent Sabatini appointed interim principal financial officer effective August 3, 2026
- Sabatini will not receive any additional compensation for the interim role
- Company has initiated a search for a permanent CFO
Financial Impact
No financial figures disclosed in the filing
Risk Factors
- Prolonged CFO vacancy could impact investor confidence and financial planning
- Potential for strategic shifts if a new CFO is brought in from outside
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (VIR) — Batch item 1 | 0001628280-26-049499 |
| Document: 0001628280-26-049499-index-headers.html | 0001628280-26-049499 |
| Document: 0001628280-26-049499-index.html | 0001628280-26-049499 |
| Document: 0001628280-26-049499.txt | 0001628280-26-049499 |
| 8-K Filing (VIR) — Batch item 5 | 0001628280-26-049499 |
| Document: 0001628280-26-049499-index-headers.html | 0001628280-26-049499 |
| Document: 0001628280-26-049499-index.html | 0001628280-26-049499 |
| Document: 0001628280-26-049499.txt | 0001628280-26-049499 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Court Ruling | $9.24 $9.78 | ▲ +5.84% | ▲ +7.21% | $11.17 (+20.89%) |
Aug 9, 2026 7w ago | Institutional Cluster | $8.89 $9.39 | ▲ +5.62% | ▲ +5.67% | $11.17 (+25.65%) |
Jul 24, 2026 10w ago | 8-K | $8.69 $8.90 | ▲ +2.42% | ▲ +2.04% | $11.17 (+28.54%) |
Jun 29, 2026 13w ago | 144 | $10.38 $10.02 | ▼ −3.47% | ▼ −4.86% | $11.17 (+7.61%) |
Jun 10, 2026 16w ago | 3 | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 10, 2026 16w ago | 8-K | $8.52 $9.30 | ▲ +9.15% | ▲ +8.72% | $11.17 (+31.10%) |
Jun 2, 2026 17w ago | Insider Cluster | $8.77 $8.25 | ▼ −5.93% | ▼ −2.11% | $11.17 (+27.37%) |
May 28, 2026 18w ago | 8-K | $9.55 $8.77 | ▼ −8.17% | ▼ −8.12% | $11.17 (+16.96%) |
Apr 16, 2026 24w ago | DEFA14A | $10.33 $10.35 | ▲ +0.19% | ▼ −0.79% | $11.17 (+8.13%) |
Apr 10, 2026 25w ago | 8-K | $9.31 $11.09 | ▲ +19.12% | ▲ +15.82% | $11.17 (+19.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access